Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Recruiting
N/A
Interventional Study
Vogt Koyanagi Harada Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 10 – 70
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 40 (estimated)
- Sponsor
- University of Sao Paulo · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective study will include patients with Vogt-Koyanagi-Harada disease from disease onset, treated with early systemic high-dose corticosteroid and immunosuppressive therapy. Clinical and subclinical signs of disease activity added with electroretinogram exams, through predefined intervals, will be evaluated through a minimum 12-month follow-up.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
\- acute Vogt-Koyanagi-Harada disease
Exclusion criteria:
* non collaborative patient
* minimum one-year follow-up
Contacts